Your chance to get on the next "60-Second Trade"

Which State Is Ranked #1 For Lithium Investors? - Ad The Fraser Institute ran a survey to find the best spot in the world for lithium mining. They researched 77 spots from around the world... and the Nevada Desert won the #1 spot by a landslide. And this small mining company just staked 11,700 acres of mineral claims in Nevada's hottest lithium spot... Continue Reading... Sponsored by Summit Publishing Group. See our disclaimer for further details on compensation, affiliation and ethics. This Is What Whales Are Betting On NIO Someone with a lot of money to spend has taken a bullish stance on NIO (NYSE:NIO). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Continue Reading... Biden to Replace US Dollar? - Ad Thanks to Biden's Executive Order 14067, every dollar you own could be in serious jeopardy. They could be made worthless, or even confiscated -- practically overnight. Continue Reading... Biden Administration Not Happy With Dennis Rodman's Russia Trip Plans To Help Brittney Griner, Here's Why The Biden administration is hoping to discourage Dennis Rodman from his planned trip to Russia to help convince the Kremlin to release WNBA star Brittney Griner.   Continue Reading... 603 ETH Worth $954K Was Just Burned What happened: On Sunday a total of 603.23 Ether (CRYPTO: ETH) worth $954,105, based on the current value of Ethereum at time of publication ($1,581.65), was burned from Ethereum transactions. Continue Reading... Buy This Oil Stock BEFORE the Ukraine War Escalates - Ad Stocks have been plummeting since Russian's invasion of Ukraine. The proposed ban of Russian oil could create a historic shock in oil prices and send oil stocks soaring. But do NOT buy Chevron or ExxonMobil. Instead, this small Texas oil stock could make you 100+% if you get in immediately, before the oil crisis escalates. Continue Reading... Check Out What Whales Are Doing With IBM A whale with a lot of money to spend has taken a noticeably bullish stance on IBM. Looking at options history for IBM (NYSE:IBM) we detected 10 strange trades. Continue Reading... FDA Grants Fast Track Status To Synlogic's Rare Genetic Disorder Drug Synlogic, Inc. (NASDAQ: SYBX) announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to its drug candidate SYNB1353 for the potential treatment of homocystinuria (HCU). SYNB1353 is currently being evaluated in a Phase 1 clinical study in healthy volunteers. Continue Reading... CEO Gets One Up on Public Investors With Secret Stock Under $5 - Ad Investors aren't supposed to know about this secret stock under $5....If word gets out, the CEO will have a much harder time taking over the tech world...And Wall Street's already buying billions of dollars worth of shares...How long will you stay in the dark? Continue Reading... Freedom Biosciences Gets $10.5M In Seed Financing For Psychedelics Research, This Is What We Know Freedom Biosciences achieved a major $10.5 million in a seed financing round in which MBX Capital, PsyMed Ventures, Village Global and The Yale Startup, among others, participated. Continue Reading... Facebook Co-Founder's VC Firm Leads $20M Funding Round For Indian Health-Tech Startup Facebook Inc (NASDAQ: META) co-founder Eduardo Saverin and Raj Ganguly's venture capital firm B Capital Group has led Series-A funding round for Indian health-tech start-up Mojocare which i Continue Reading... PhD who walked away from her million-dollar career at Goldman Sachs says "Strange new normal coming" - Ad Few believed Nomi Prins when she called the 2008 meltdown well in advance. Now, she's issuing a new prediction. Most Americans aren't yet prepared. Continue Reading... Why Zoom Video Is Trading Lower By 11%; Here Are 28 Stocks Moving Premarket Gainers Quotient Limited (NASDAQ: QTNT) shares rose 58.2% to $0.3070 in pre-market trading. Quotient recently reported a wider Q1 loss. Continue Reading... Merck Gets FDA Fast Track Status For Chronic Kidney Disease Candidate The U.S. Food and Drug Administration (FDA) has granted Fast Track designation for Merck's (NYSE: MRK) lead asset MK-2060 for the reduction in risk of major thrombotic cardiovascular events in patients with end-stage renal disease (ESRD). Continue Reading... Jim Cramer Is Staying Away From This Stock, Says It's The 'Best One Of A Bad Neighborhood' On CNBC's "Mad Money Lightning Round," Jim Cramer said ChargePoint Holdings, Inc. Continue Reading... Sony's New Virtual Reality Headset Gets A Debut Update: What Investors Should Know The highly anticipated virtual reality (VR) headset from Sony Group Corp. (NYSE: SONY) has a new updated release timeline. Here's when fans can get their hands on the new PlayStation device. Continue Reading... 5 Real Estate Stocks You Should Own Right Now - Ad Lucrative investment opportunities are always found in real estate. Real estate stocks can be an alternative way to invest in this area, without needing to purchase property. Here are the hottest stocks in this field. GET THE REPORT NOW! By clicking the link above you will automatically opt-in to receive emails from TechnicalTrading and agree to Privacy Policy The Best Bargain Stock Under $10 Investing in stocks under $10 could significantly increase the returns on your portfolio, especially if you pick the right stocks. Add this bargain stock to your watchlist before it takes off! Continue Reading... Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. This is not individualized investment management. This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. If you wish to no longer receive these offers click on the unsubscribe link at the bottom of this email. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended in this email and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained in this email or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault. Copyright © 2022. Musth | TrendAdvisor 339-20 De Boers Dr, Toronto, ON M3J 0H1 | Unsubscribe